Nav: Home

Over half of ED visits for nonmedical prescription drug use are patients under 35

March 06, 2019

Ann Arbor, March 6, 2019 - Nonmedical prescription drug use is a common cause of emergency department (ED) visits in the United States for medication-related harm, but data on effects of nonmedical use of pharmaceuticals are limited. Using nationally representative public health surveillance data to characterize US ED visits for harm caused by nonmedical prescription drug use, investigators at CDC and FDA report in the American Journal of Preventive Medicine that over half these visits are by young adults under 35, and over 40 percent of patients arrive unconscious or after cardiorespiratory failure. They include recommendations to guide prevention efforts.

Nonmedical prescription drug use, generally defined as use without a prescription or use for reasons other than for which the medication is intended, is a global concern. The increase in morbidity from prescription opioids has been called an epidemic, and overdoses from both prescription and illicit opioids led the US Department of Health and Human Services (HHS) to declare a public health emergency in 2017.

Previous studies have shown that prescription opioids and benzodiazepines are commonly misused (by 11.5 million and 5.6 million individuals in the US, respectively, in 2016). However, since discontinuation of the Drug Abuse Warning Network after 2011, detailed national data describing morbidity from nonmedical use of pharmaceuticals are limited.

The investigation, led by Andrew Geller, MD, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA, reviewed data from a nationally-representative data source, the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project, to identify the medications with the highest numbers of ED visits for harms following nonmedical use of medications and identify patients at greatest risk.

Findings from this study quantify how often prescription opioids, benzodiazepines, and other medications cause ED visits after nonmedical use, either alone or in combination. In the US, harm from nonmedical use of pharmaceuticals led to about 360,000 ED visits in the US in 2016, most frequently benzodiazepines and opioids, most commonly in combinations with other substances such as illicit drugs and alcohol. The adverse effects of nonmedical use of medications were frequently serious, with nearly one-quarter of patients unresponsive or experiencing cardiorespiratory failure, and two-fifths of patients requiring hospitalization. There are also concerns about nonmedical use of non-benzodiazepine sleeping aids, stimulants, cough and cold products, and gabapentinoids.

The data showed that in the US in 2016, there were an estimated 358,247 ED visits for harms from nonmedical use of medications.
  • Two-fifths (41 percent) of these ED visits resulted in hospitalization, and nearly one-quarter (22.6 percent) of visits involved patients who were unresponsive or had experienced cardiorespiratory failure.

  • One half (50.9 percent) of these visits involved patients younger than 35 years of age. Only one in twenty (4.9 percent) visits involved older adults (aged 65 or more years old).

  • Benzodiazepines were the most commonly implicated medication (47 percent), followed by prescription opioids (36 percent).

  • Other substances such as alcohol, heroin, cocaine, and other illicit substances, or medications were involved in 85 percent of benzodiazepine cases and 69 percent of prescription opioid cases.

The investigators point out that although patients treated for nonfatal overdose have increased risk of another overdose, naloxone, which has shown efficacy in tertiary prevention of fatal opioid overdoses, is not routinely made available to overdose patients at ED discharge. They propose that efforts to expand naloxone distribution could initially target patients who receive emergency care for serious overdose symptoms. In addition, the ED can be a place to begin secondary preventive interventions, such as brief motivational interviewing, connecting patients to peer navigators for follow-up, and linking to or initiating medication-assisted treatment.

Because other substances and additional pharmaceuticals are most often involved, prescribing clinicians should consider implementing specific screening to address polysubstance use and, when warranted, treatment interventions.

For patients, family members, and healthcare providers, these findings highlight areas in which interventions can likely reduce patient harm. First, patients who have been brought to an ED for overdoses after nonmedical use of opioids (or their family or friends) may be the most appropriate people to offer naloxone.

Preventing an overdose is preferable to rescuing a patient after an overdose, but because ED visits most often involve nonmedical use of combinations of illicit substances, alcohol, and medications, a fully effective harm reduction strategy should include screening and treatment for polysubstance use.
-end-


Elsevier

Related Opioids Articles:

Most reproductive-age women using opioids also use another substance
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate School of Public Health analysis.
At-risk chronic pain patients taper opioids successfully with psychological tools
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids.
More than half of all opioid prescriptions go to people with mental illness
Fifty-one percent of all opioid medications distributed in the US each year are prescribed to adults with mood disorders such as depression and anxiety, according to new research from the University of Michigan and the Geisel School of Medicine at Dartmouth.
Study examines opioid use in patients with rheumatoid arthritis
A new analysis indicates that the use of opioid pain medications in older US rheumatoid arthritis patients peaked in 2010 and is now declining slightly.
Depressed patients more likely to be prescribed opioids
A new study shows that patients with low back pain who were depressed were more likely to be prescribed opioids and receive higher doses.
Women who focus negatively, magnify chronic pain, more likely to be taking prescribed opioids
Female chronic pain sufferers who catastrophize, a psychological condition in which pain is exaggerated or irrationally focused on, not only report greater pain intensity, but are more likely to be taking prescribed opioids than men with the same condition, according to a study published Online First in Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists (ASA).
Opioids following cesarean delivery may be over-prescribed
In two papers, both published online June 8 in Obstetrics & Gynecology, researchers quantified the number of pills that are typically prescribed following cesarean delivery and tested a shared decision making tool, in which patients select the amount of medication they are prescribed.
One in 5 surgical weight-loss patients take prescription opioids 7 years after surgery
While the proportion of adults with severe obesity using prescription opioids initially declines in the months after bariatric surgery, it increases within a matter of years, eventually surpassing pre-surgery rates of patients using the potentially addictive pain medications, according to new research from a National Institutes of Health (NIH)-funded multicenter study led by the University of Pittsburgh Graduate School of Public Health.
Brain opioids help us to relate with others
A new Finnish research reveals how brain's opioids modulate responses towards other people's pain.
Worse pain outcomes after knee replacement for patients who took opioids before surgery
Six months after knee replacement surgery, pain outcomes were not as good for patients who previously took prescription opioids, according to a study in the May 17 issue of The Journal of Bone & Joint Surgery.

Related Opioids Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...